A BRIEF REVIEW ON ROLE OF COMPUTER AIDED DRUG DESIGN IN THE DEVELOPMENT OF VITAL TYROSINE KINASE INHIBITOR COMPOUNDS

Computer-aided drug design has developed as a prevailing technique playing a vital role in the progress of new drug molecules over the past couple of decades. There are certain drugs which was designed, optimized, synthesized, patented and marketed by the application of computer aided drug designing. This review focussed on the reputation of computer aided drug design in the development of vital tyrosine kinase inhibitor compounds for the treatment of different type of cancers. Drugs with Tyrosine kinase inhibitory activity involves Receptor Tyrosine Kinase Inhibitors (RTK inhibitors), Non-Receptor Tyrosine Kinase Inhibitors (NRTK inhibiotors), and Multi-targeted Tyrosine Kinase Inhibitors. (1) Key Words: Computer Aided Drug Design, Receptor Tyrosine Kinase Inhibitors, VEGFR

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24317032
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A BRIEF REVIEW ON ROLE OF COMPUTER AIDED DRUG DESIGN IN THE DEVELOPMENT OF VITAL TYROSINE KINASE INHIBITOR COMPOUNDS

Manju M. Nair, SEBA M C, TINU B SHAJI, NEETHU M S et al.
Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

A BRIEF REVIEW ON ROLE OF COMPUTER AIDED DRUG DESIGN IN THE DEVELOPMENT OF VITAL TYROSINE KINASE INHIBITOR COMPOUNDS

Manju M. Nair, SEBA M C, TINU B SHAJI, NEETHU M S, ANOOPA JOHN, KRISHNA M S
article en

Abstract

Computer-aided drug design has developed as a prevailing technique playing a vital role in the progress of new drug molecules over the past couple of decades. There are certain drugs which was designed, optimized, synthesized, patented and marketed by the application of computer aided drug designing. This review focussed on the reputation of computer aided drug design in the development of vital tyrosine kinase inhibitor compounds for the treatment of different type of cancers. Drugs with Tyrosine kinase inhibitory activity involves Receptor Tyrosine Kinase Inhibitors (RTK inhibitors), Non-Receptor Tyrosine Kinase Inhibitors (NRTK inhibiotors), and Multi-targeted Tyrosine Kinase Inhibitors. (1) Key Words: Computer Aided Drug Design, Receptor Tyrosine Kinase Inhibitors, VEGFR

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon